Transcriptomic Signature Differences Between SARS-CoV-2 and Influenza Virus Infected Patients.

Stéphanie Bibert1, Nicolas Guex2, Joao Lourenco3

  • 1Infectious Diseases Service, Department of Medicine, University Hospital and University of Lausanne, Lausanne, Switzerland.

Summary

Understanding COVID-19 severity requires examining immune responses. This study reveals distinct SARS-CoV-2 immune signatures, including altered interferon and neutrophil activity, differing by disease severity.